Free Trial

Concord Medical Services (CCM) Competitors

Concord Medical Services logo
$5.29 +0.05 (+0.97%)
As of 09/5/2025 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CCM vs. BNR, EUDA, ATPC, BDSX, PIII, BMGL, KDLY, MRAI, MGRX, and BRTX

Should you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include Burning Rock Biotech (BNR), EUDA Health (EUDA), Agape ATP (ATPC), Biodesix (BDSX), P3 Health Partners (PIII), Basel Medical Group (BMGL), Kindly MD (KDLY), Marpai (MRAI), Mangoceuticals (MGRX), and Biorestorative Therapies (BRTX). These companies are all part of the "healthcare" industry.

Concord Medical Services vs. Its Competitors

Concord Medical Services (NYSE:CCM) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Concord Medical Services had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 1 mentions for Concord Medical Services and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.00 beat Concord Medical Services' score of -1.00 indicating that Burning Rock Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Concord Medical Services Negative
Burning Rock Biotech Neutral

30.0% of Burning Rock Biotech shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Concord Medical Services has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -45.41%. Concord Medical Services' return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
Burning Rock Biotech -45.41%-38.33%-25.34%

Concord Medical Services has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500.

Concord Medical Services has higher earnings, but lower revenue than Burning Rock Biotech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$52.60M0.44-$42.23MN/AN/A
Burning Rock Biotech$523.28M0.17-$47.49M-$1.89-4.39

Summary

Concord Medical Services beats Burning Rock Biotech on 7 of the 11 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCM vs. The Competition

MetricConcord Medical ServicesMED IndustryMedical SectorNYSE Exchange
Market Cap$23.88M$3.41B$5.83B$21.36B
Dividend YieldN/A1.19%6.70%3.49%
P/E RatioN/A12.1876.1529.62
Price / Sales0.441.18553.2669.38
Price / CashN/A16.3636.9925.18
Price / Book0.103.6311.484.55
Net Income-$42.23M$38.94M$3.29B$999.70M
7 Day Performance1.24%0.92%1.28%0.58%
1 Month Performance2.54%9.75%8.56%5.67%
1 Year Performance-9.48%7.20%61.19%18.25%

Concord Medical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCM
Concord Medical Services
0.4799 of 5 stars
$5.29
+1.0%
N/A-9.5%$23.88M$52.60M0.00970Short Interest ↑
Gap Up
BNR
Burning Rock Biotech
N/A$8.09
-7.0%
N/A+78.8%$87.00M$70.67M-4.281,390Upcoming Earnings
Gap Up
EUDA
EUDA Health
0.511 of 5 stars
$1.86
-9.9%
N/A-51.0%$69.04M$4.01M0.002News Coverage
Short Interest ↑
ATPC
Agape ATP
0.7401 of 5 stars
$1.33
+1.5%
N/A-22.3%$66.51M$1.32M-3.2440Positive News
Short Interest ↓
Gap Up
BDSX
Biodesix
3.4454 of 5 stars
$0.44
+3.6%
$1.75
+295.9%
-76.1%$64.81M$71.32M-1.52220News Coverage
Positive News
Insider Trade
PIII
P3 Health Partners
3.1039 of 5 stars
$8.33
-0.1%
$16.25
+95.2%
-61.9%$59.86M$1.50B-0.18500News Coverage
Positive News
Short Interest ↓
BMGL
Basel Medical Group
N/A$1.98
-2.9%
N/AN/A$36.53MN/A0.0036Positive News
Gap Down
KDLY
Kindly MD
N/A$5.44
-8.3%
N/A+205.6%$32.76M$2.47M-7.06N/AGap Up
MRAI
Marpai
N/A$1.38
-2.1%
N/A+94.2%$23.83M$34.87M-0.52150
MGRX
Mangoceuticals
1.7842 of 5 stars
$2.13
-10.0%
N/A-96.3%$22.39M$620K-0.553News Coverage
Short Interest ↓
BRTX
Biorestorative Therapies
1.2549 of 5 stars
$1.75
-4.7%
N/A+4.6%$14.00M$400K-1.387

Related Companies and Tools


This page (NYSE:CCM) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners